+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Celldex Therapeutics, Inc.  - logo

Celldex Therapeutics is a biopharmaceutical company that develops, manufactures, and commercializes novel therapeutics for human health care. The company's pipeline is comprised of therapeutic antibodies, antibody drug conjugates, immune system modulators and vaccines. The company's lead drug candidates are Rintega, Glembatumumab vedotin, Varlilumab and others. In 2005, Celldex was spun out of the New Jersey based biopharmaceutical company Medarex. It is now headquartered in Hampton, New Jersey.

From
From
From
Neuroblastoma (Oncology) - Drugs in Development, 2021 - Product Thumbnail Image

Neuroblastoma (Oncology) - Drugs in Development, 2021

  • Report
  • October 2021
  • 1265 Pages
From
From
From
Brain Hemorrhage - Pipeline Insight, 2020 - Product Thumbnail Image

Brain Hemorrhage - Pipeline Insight, 2020

  • Clinical Trials
  • February 2020
  • 106 Pages
From
Liver Cancer - Pipeline Insight, 2022 - Product Thumbnail Image

Liver Cancer - Pipeline Insight, 2022

  • Clinical Trials
  • June 2022
  • 210 Pages
From
Thyroid Cancer - Pipeline Insight, 2022 - Product Thumbnail Image

Thyroid Cancer - Pipeline Insight, 2022

  • Clinical Trials
  • May 2022
  • 180 Pages
From
From
From
From
From
Loading Indicator